Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,194.7
20.5 (0.65%)

 

  • STI Straits Times Index
    3,194.7
    20.5 (0.65%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,568.4
    4.9 (0.31%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,498.4
    281.3 (1.07%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,912.0
    12.5 (0.43%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,354.4
    54.3 (0.23%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,186.9
    34.8 (0.56%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,081.8
    21.1 (1.02%)
    Index delayed 20 minutes
  • XAO XAO
    6,813.5
    22.4 (0.33%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 718.9M
  • Value: 1,161.4M
  • Rise: 142
  • Fall: 133
  • Unch: 551

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Golden Agri-Res0.220-0.010
YZJ Shipbldg SGD1.110+0.010
Rex Intl0.169-0.005
Tritech0.024-0.002
SingTel3.430+0.020
OCBC Bank10.710+0.060
Genting Sing0.920+0.005
Mapletree Log Tr1.740+0.020
Mapletree NAC Tr1.180+0.030
ThaiBev0.900+0.005

World Indices

World Indices
Name Last Change
Nasdaq 8,656.5 +85.8
HSI 26,498.4 +281.3
HSCEI 10,407.2 +85.3
Jakarta 6,186.9 +34.8
Nikkei 225 23,354.4 +54.3
SSE Comp 2,912.0 +12.6
Shanghai A 3,051.3 +13.1
Shanghai B 243.4 +1.8
PSE Comp 0.0
KOSPI 2,081.8 +21.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NEXTCURE INC NEXTCURE
Updated on 06 Dec 2019 (End of trading day)
Last (USD): 50.270 Change: +0.350 High: 51.695 Remarks: -
Change (%): +0.70 Low: 49.650
Open 49.650 Yesterday's Close 49.92
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 303,080 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.84973 Trailing EPS (USD) e -0.84973 NAV (USD) b 6.3601
PE a - Trailing PE f - Price / NAV b 7.9040
Dividend (USD) d - Cash In Hand (USD) g 0.4183 Issued & Paid-up Shares c 26,831,000
Dividend Yield (%) d - Price / Cash In Hand g 120.177 Treasury Shares h -
Beta - 75 Daysi 0.675 R-Squared - 75 Days(%)i 0.02 Market Cap (M) 1,348.794
Beta - 500 Daysi 0.188 R-Squared - 500 Days (%)i - Enterprise Value (M) 1,168.423
Piotroski F Score 5 Exchange Code NXTC Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 45.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 18 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 May 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NEXTCURE INC NASDAQ 1,348.794 - - 7.9040 -
Industry Biotechnology NASDAQ 2,342.596 403.412 168.111 5.8606 0.746
Local Peer AMGEN INC NASDAQ 138,902.394 16.548 17.219 12.7119 2.393
Local Peer GILEAD SCIENCES INC NASDAQ 84,866.262 15.558 31.514 4.1189 3.444
Local Peer VERTEX PHARMACEUTICAL NASDAQ 57,408.738 27.385 26.779 10.9279 -
Local Peer BIOGEN INC NASDAQ 54,179.515 12.228 10.041 3.8711 -
Local Peer ILLUMINA INC NASDAQ 47,991.090 58.101 49.323 10.8112 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 40,872.648 16.721 19.062 3.8910 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 25,202.832 324.778 17.141 2.4310 -
Local Peer INCYTE CORPORATION NASDAQ 20,350.709 185.864 50.253 8.4006 -
Local Peer SEATTLE GENETICS INC NASDAQ 20,137.855 - - 11.3159 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 14,355.630 - - 4.6694 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 13,806.405 - 44.485 4.9951 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 13,798.002 - - 8.5857 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), REPLIGEN CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), UNIQURE N.V. (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), XENCOR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ARVINAS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), VIELA BIO INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), INTREXON CORP (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), SYNTHORX INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), CORTEXYME INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), OMEROS CORP (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), TRANSLATE BIO INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), RETROPHIN INC (NASDAQ), AVROBIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), AGENUS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MERUS B V (NASDAQ), XBIOTECH INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), DERMIRA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BELLUS HEALTH INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ANAPTYSBIO INC (NASDAQ), RECRO PHARMA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), COMPUGEN (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), AVID BIOSERVICES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), GERON CORP (NASDAQ), KAMADA (NASDAQ), PERSONALIS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), CHIASMA INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CABALETTA BIO INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ARAVIVE INC (NASDAQ), NANTKWEST INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHIMERIX INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), IMV INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), NOVAVAX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), INFLARX N V (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), OTONOMY INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VERMILLION INC (NASDAQ), VACCINEX INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), TREVENA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), INMUNE BIO INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), RESTORBIO INC (NASDAQ), SAVARA INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ORGENESIS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ZAFGEN INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SOLIGENIX INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ATYR PHARMA INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENESTECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), TOCAGEN INC (NASDAQ), VAXART INC (NASDAQ), PRECIPIO INC (NASDAQ), OCUGEN INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), TROVAGENE INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), OPGEN INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SPHERIX INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ)
Global Peer CSL ASX 127,536.908 47.537 47.537 17.0432 0.944
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 25,230.926 79.844 23.558 5.3140 0.751
Global Peer SINO BIOPHARM HKEx 133,071.382 12.419 12.889 3.9630 0.692
Global Peer WUXI BIO HKEx 117,659.172 157.529 123.151 12.1115 -
Global Peer BEIGENE HKEx 91,144.197 - - 9.0939 -
Global Peer GENSCRIPT BIO HKEx 36,803.239 221.324 - 10.3784 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer 3SBIO HKEx 28,346.065 18.738 22.807 2.7938 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,714.390 43.292 631.253 2.6226 -
Other Global Peers HAOHAI BIOTEC (HKEx), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), CKLIFE SCIENCES (HKEx), VIVA BIOTECH (HKEx), AVITA MEDICAL LTD (ASX), ASCENTAGE-B (HKEx), POLYNOVO LIMITED (ASX), MESOBLAST LTD (ASX), KADMON HLDGS INC (NYSE), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), TELIX PHARMACEUTIC (ASX), LEE'S PHARM (HKEx), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), DPHARMA (Bursa), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), BBI LIFE SCI (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), NANOVIRICIDES INC (NYSE American), RESAPP HEALTH LIMITED (ASX), ENZO BIOCHEM INC (NYSE), UNI-BIO GROUP (HKEx), PALATIN TECHNOLOGIES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), PYC THERAPEUTICS LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), IMUGENE LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), ONCOSIL MEDICAL LIMITED (ASX), CEL-SCI CORP (NYSE American), IMMUTEP LTD (ASX), ORTHOCELL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), BIOSINO BIO-TEC (HKEx), ACTINOGEN MEDICAL LTD (ASX), ISORAY INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), REGENT PACIFIC (HKEx), NOVITA HEALTHCARE LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ORAGENICS INC (NYSE American), MEMPHASYS LTD (ASX), IBIO INC (NYSE American), BIOTRON (ASX), RHINOMED LIMITED (ASX), EXTRAWELL PHAR (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), PROTEOMICS INTL LABORATORIES LTD (ASX), ANTEOTECH LIMITED (ASX), REGENEUS LTD (ASX), IMMURON LIMITED (ASX), CELLMID LIMITED (ASX), PATRYS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), Suntar Eco-City^ (SGX), ALTERITY THERAPEUTICS LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), HOLISTA COLLTECH LIMITED (ASX), ADALTA LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CCP TECHNOLOGIES LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), BENITEC BIOPHARMA LTD (ASX), MEGASUN (Bursa), MEDIBIO LIMITED (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), MGRC (Bursa), HAO WEN HLDGS (HKEx), ANATARA LIFESCIENCES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), QT Vascular (SGX), AVECHO BIOTECHNOLOGY LTD (ASX), AIM IMMUNOTECH INC (NYSE American), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+2.460
+5.15 %
10 Days -+13.460
+36.57 %
20 Days --32.620
-39.35 %
Medium Term Return 3 Months -+15.930
+46.39 %
6 Months -+33.700
+203.38 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 13.860 - 109.000 Change From 1 Year Low +36.410 % Change From 1 Year Low (%) +262.70
Change From 1 Year High -58.730 % Change From 1 Year High (%) -53.88
2 Years Range 13.860 - 109.000 Change From 2 Years Low +36.410 % Change From 2 Years Low (%) +262.70
Change From 2 Years High -58.730 % Change From 2 Years High (%) -53.88
5 Years Range 13.860 - 109.000 Change From 5 Years Low +36.410 % Change From 5 Years Low (%) +262.70
Change From 5 Years High -58.730 % Change From 5 Years High (%) -53.88
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lieping Chen in September 2015 and is headquartered in Beltsville, MD.

Historical Price Data

Date Open High Low Close Volume VWAP
06 Dec 2019 49.650 51.695 49.650 50.270 303,080 -
05 Dec 2019 52.430 52.720 49.510 49.920 457,677 -
04 Dec 2019 47.310 51.740 45.750 51.010 579,936 -
03 Dec 2019 42.170 48.120 42.050 47.200 470,821 -
02 Dec 2019 48.300 48.860 42.700 43.590 632,343 -
29 Nov 2019 40.970 49.170 40.970 47.810 733,762 -
27 Nov 2019 40.200 42.249 39.802 40.940 485,882 -
26 Nov 2019 40.800 41.000 39.000 39.940 544,549 -
25 Nov 2019 36.750 41.730 36.750 39.840 1,100,745 -
22 Nov 2019 36.590 37.510 36.249 36.810 462,944 -
21 Nov 2019 36.200 37.260 35.940 36.340 535,867 -
20 Nov 2019 36.600 36.700 35.640 36.500 383,987 -
19 Nov 2019 36.690 36.930 35.220 36.000 473,971 -
18 Nov 2019 36.140 37.300 35.950 36.350 365,428 -
15 Nov 2019 37.860 38.640 34.410 36.050 2,106,338 -
14 Nov 2019 37.650 38.600 36.310 38.550 480,464 -
13 Nov 2019 35.510 38.428 34.690 37.750 575,600 -
12 Nov 2019 38.990 40.480 36.230 37.410 703,154 -
11 Nov 2019 37.530 43.990 37.050 39.020 3,102,193 -
08 Nov 2019 77.120 86.000 75.470 82.890 627,938 -
07 Nov 2019 65.420 81.795 65.205 79.410 622,056 -
06 Nov 2019 87.500 89.000 61.520 67.010 2,573,641 -
Summary
Current 2 Weeks
(22 Nov 2019 to 06 Dec 2019)
36.590 52.720 36.249 50.270 5,771,739 -
Previous 2 Weeks
(08 Nov 2019 to 21 Nov 2019)
77.120 86.000 36.249 36.340 9,354,940 -
4 Weeks from
(11 Oct 2019 to 07 Nov 2019)
26.300 52.720 26.120 79.410 12,842,600 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.